Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3759673019 | Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3759674013 | Tiagabine (as tiagabine hydrochloride monohydrate) 5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Tiagabine hydrochloride monohydrate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Tiagabine only product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Tiagabine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR